A Study to Evaluate the Comparative Bioavailability of the Investigational Oral Pediatric Minitablet Formulation of MK-1439 Compared to the Adult Formulation of MK-1439 in Healthy Adult Subjects
Latest Information Update: 12 Dec 2016
At a glance
- Drugs Doravirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 12 Dec 2016 Status changed from not stated to recruiting.
- 25 Nov 2016 New trial record